Sign in

Lost your password?
(close)

Actelion Turkey

Last updated: 07.07.2015

 

unknownACTELION IS A FULLY-INTERGRATED BIOPHARMACEUTICAL COMPANY WITH INNOVATION AT ITS CORE.

Actelion is the leader in the science and medicine of pulmonary arterial hypertension (PAH), with over 15 years of experience. With an in depth understanding of the complex pathways and molecular mechanisms of this disease, Actelion has successfully developed tailored medicines that can make a real difference to patient outcomes.

Innovative products Veletri, Opsumit assure Actelion’s leadership in the field of PAH into the mid-2020s, with their candidate product selexipag, developed in partnership with Nippon Shinyaku, currently under review with Health Authorities.

In depth expertise in human biology, especially the knowledge of specific families of molecular targets, such as G-Protein Coupled Receptors, led Actelion to Opsumit and it is this knowledge that will take the company to new areas.

Actelion leverages our scientific expertise through in-house discovery, development and marketing talents; ‘fully-integrated’ also means that they have all the expertise in all areas of the value chain for delivering great products to physicians, patients, payors – as well as all the support functions and infrastructure needed to deliver their ambition efficiently.

Contact Details
Actelion Ilac Ltd.Sti.
Kurucesme Cad. Kirbac Sok. No:17/4
Kurucesme 34345 Istanbul
Turkiye

Phone: +90 212 362 10 00
Fax: +90 212 257 02 67

 

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here